Abstract

Acute kidney injury (AKI) describes a heterogeneous group of conditions, without specification of their etiology and diagnosed only by indirect markers of glomerular filtration rate (GFR), such as serum creatinine and urine output. Bedside estimation of GFR and detection of structural alterations with novel biomarkers, and stress tests have more recently been developed. These novel findings should probably be included in future AKI definitions. Chronic kidney disease (CKD) is defined by abnormalities in kidney function and structure that persist over >3 months and is classified according to cause, GFR, and albuminuria. Acute kidney disease (AKD) is the term representing patients with abnormalities of function and structure with a duration of ≤3 months that fall outside the definitions of AKI or CKD. Since AKI is by definition also AKD, 2 types of AKD have been proposed, one with and one without AKI. AKD without AKI is common, often undetected, occurs frequently in the outpatient population and shows increased risk of CKD, ESKD and mortality. Alternatively, AKD has also been defined as the period of incomplete recovery following an AKI episode, the latter limited for the duration of 7 days. This contribution discusses the pros and cons of the existence of these 2 definitions of AKD.

Highlights

  • Academic Editor: Vladimir TesarThe KDIGO Acute Kidney Injury (AKI) guidelines [1] were published in early 2012 and are based on evidence gathered until mid-2011

  • GFR: glomerular filtration rate; SCr: serum creatinine. * Kidney damage can be assessed by blood or urine markers of the definition and novel classification ofimaging, AKI [1,4,5,6,7,8,9,10,11]

  • AKI is the generic term for a heterogeneous group of conditions characterized by an abrupt and sustained decrease in GFR, occurring over ≤7 days and is diagnosed by an increase in serum creatinine (SCr) or with a decrease in 6 h urinary output (UO), as shown in the table [1]

Read more

Summary

Introduction

The KDIGO Acute Kidney Injury (AKI) guidelines [1] were published in early 2012 and are based on evidence gathered until mid-2011. This resulted in “consensus” opinions with only 22 (25%) “strong “recommendations, reflecting the paucity of high-level data guiding the management of AKI at that time. Kidney Diseases (KDs) are defined by markers of kidney damage (structural criteria) and/or decreased (estimated) glomerular filtration rate (GFR) (functional criteria) persisting for ≤3 months (AKD) or ≥3 months (CKD). * Kidney damage can be assessed by blood or urine markers of the definition and novel classification ofimaging, AKI [1,4,5,6,7,8,9,10,11]. Biomarkers), or biopsy results). ** oliguria is defined as urine volume

Acute Kidney
Alternative Estimates of GFR
Renal Stress Tests
Furosemide Stress Test
The Concept of AKD and Its Interrelationship with AKI and CKD
Findings
Conclusions and Future Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call